• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.4735 -0.0205 (-4.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
March 12, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Reverse Stock Split
March 06, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
March 03, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
February 26, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
February 10, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
January 29, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
December 17, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Third Quarter 2025 Financial Results
November 06, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Specificity (OTCQB: SPTY) Signs LOI with Blackpearl – Global Push to End $250B Ad Tech Fraud – More Stocks Inside
October 30, 2025
Via AB Newswire
Topics Artificial Intelligence Fraud
News headline image
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
October 30, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
September 16, 2025
- Strategic expansion with trusted partner enhances customer reach 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
September 09, 2025
Veteran life sciences industry financing leader appointed as new Board member 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Second Quarter 2025 Financial Results
August 11, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
August 04, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
July 17, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Appoints John Duke to Board of Directors
June 02, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces First Quarter 2025 Financial Results
May 12, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
May 05, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces CFO Transition
April 10, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
March 12, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
March 12, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
February 24, 2025
Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
February 24, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Third Quarter 2024 Financial Results
November 07, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
October 29, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
October 03, 2024
New products complement an already extensive range of products enabling fundamental advancements in neuroscience research 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
September 18, 2024
Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Second Quarter 2024 Financial Results
August 08, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
August 02, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
June 06, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap